Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Real Life Effectiveness and Tolerability of Cladribine Tablets (CladT) after Five Years of Treatment

Author:Pato Pato, Antonio   Lorenzo González, José Ramón   García Estévez, Daniel Apolinar   López Real, Ana María   Rodriguez Regal, Ana   Costa Arpin, Eva   Rodriguez Rodriguez, María   Alvarez Rodriguez, Elena   Alberte Woodgard, Miguel   Aguado Valcarcel, Marta   González Suarez, Inés   Prieto Gonzalez, José María Oscar   

Session Name:P4: Multiple Sclerosis: Health Services/Outcomes Research and Real-world Evidence 4  

Topic:Multiple Sclerosis  

Program Number:Multiple Sclerosis  

Author Institution:Complexo Hospitalario de Vigo, Vigo, Spain  Hospital Povisa de Vigo, Vigo, Spain  Complexo Hospitalario de Ourense, Ourense, Spain  Complexo Hospitalario de A Coruña, A Coruña, Spain  Complexo Hospitalario de Pontevedra, Pontevedra, Spain  Complexo Hospitalario de Ferrol, Ferrol, Spain  Hospital Universitario Lucus Augusti, Lugo, Spain  Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain  

Real-world Digital Biomarkers Associated With Their Clinical Counterparts in the MS-DETECT Study

Author:Vermersch, Patrick   Filippi, Massimo   Oreja-Guevara, Celia   Oh, Jiwon   Sejbæk, Tobias   Graves, Jennifer   Klaeylé, Lissandra   Bieuvelet, Séverine   Carment, Loïc   DROUIN, Pierre   Zinaï, Saad   Rufi, Pascal   Padrazzi, Bruno   Ziemssen, Tjalf   

Session Name:P4: Multiple Sclerosis: Digital Health, Biomarkers, and Artificial Intelligence 1  

Topic:Multiple Sclerosis  

Program Number:Multiple Sclerosis  

Author Institution:Univ. Lille, UMR Inserm U1172, CHU Lille, Lille, France, Lille, France  Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy, Milan, Italy  Hospital Clinico San Carlos, IdISSC, Madrid, Spain, Madrid, Spain  Division of Neurology, St. Michael’s Hospital, University of Toronto, Toronto, Canada, Toronto, ON, Canada  Department of Neurology, Esbjerg Hospital, University Hospital of Southern Denmark, Esbjerg, Denmark, Esbjerg, Denmark  Department of Neurosciences, University of California San Diego, San Diego, CA, USA, San Diego, CA  Ad Scientiam, Paris, France, Paris, France  Sanofi, Paris, France, Chilly-Mazerins, France  MS Center, Center of Clinical Neuroscience, Neurological Clinic, University Clinic Carl Gustav Carus, TU Dresden, Dresden, Germany, Dresden, Germany  

Defining Progression Independent of Relapse Activity in Early Multiple Sclerosis

Author:Ayaz, Taha   Emekli, Ahmed Serkan   Gunduz, Tuncay   Kurtuncu, Murat   

Session Name:P4: Multiple Sclerosis: Clinical Science 1  

Topic:Multiple Sclerosis  

Program Number:Multiple Sclerosis  

Author Institution:Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye, Istanbul, Turkey  

Air Pollution and the Risk and Progression of Multiple Sclerosis: A Systematic Review and Meta-analysis

Author:Toubasi, Ahmad   Al-Sayegh, Thuraya   

Session Name:P4: Multiple Sclerosis: Clinical Science 1  

Topic:Multiple Sclerosis  

Program Number:Multiple Sclerosis  

Author Institution:Vanderbilt University Medical Center, Nashville, TN  University of California San Francesco, Fresno, CA  

Reducing the Risk of PIRA in RRMS: The Value of High-efficacy Disease- Modifying Therapies

Author:Guarnaschelli, Maria Flor   Marrodan, Mariano   Sosa, Braian   Perez Arana, Carolina   Farez, Mauricio   Fiol, Marcela   Celica, Ysrraelit   Correale, Jorge   

Session Name:P4: Multiple Sclerosis: Health Services/Outcomes Research and Real-world Evidence 4  

Topic:Multiple Sclerosis  

Program Number:Multiple Sclerosis  

Author Institution:FLENI, City of Buenos Aires, Argentina  Institute for Neurological Research, Buenos Aires, Argentina